Ludwig Institute for Cancer Research

Analysis

Ludwig Institute for Cancer Research is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in August 1971, 55 years ago. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Ludwig Institute for Cancer Research reported income of $72.9m and spending of $71.4m, spending 98% of its income. Across the 5 years on record, from December 2019 to December 2023, income fell from $80.5m to $72.9m (-9.4%), an average of -2.4% a year. The sharpest change came in the year to December 2023, when income dropped by 29%. Over the whole period it spent 100% of the income it received.

Among 72,936 United States charities whose main cause is other charitable purposes and that reported income, Ludwig Institute for Cancer Research sits at the 99th percentile: it is one of the largest 1% in its cause. Against every charity in United States with reported income it ranks in the 99th percentile, and in the 98th percentile within NY. Charities of a similar size with the same main cause include Usvets Housing Corporation ($72.8m), Northeast Arc Inc ($73.4m) and Stella Maris Inc ($72.8m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 96% of the total. Compensation of current officers, directors and key employees was $4.0m (5.6% of expenses). Other salaries and wages came to $9.0m. At year end it held assets of $19.3m against liabilities of $16.6m, net assets of $2.7m. It reported 48 employees.